UtibaprilAlternative Names: FPL 63547; FPL 63674
Latest Information Update: 22 Dec 1995
At a glance
- Originator Fisons
- Class Antihypertensives
- Mechanism of Action ACE inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Heart failure; Hypertension
Most Recent Events
- 22 Dec 1995 Discontinued-II for Hypertension in United Kingdom (Unknown route)
- 22 Dec 1995 Discontinued-II for Heart failure in United Kingdom (Unknown route)